Pfizer has released footage of a potential Pfizer coronavirus vaccine coming off the production line as the drug giant seeks to prepare 100 million doses by the end of the year.
The Manhattan-based company told the Mail on Sunday that it had already made “several hundred thousand doses” of the drug, preparing for emergency use in the United States by November.
The firm’s head of the firm, Ben Osborne, also told the newspaper that scientists from its main British laboratory had also discovered drugs that could provide a potential complete cure for Covid-19, as opposed to just a prophylactic vaccine.
Osborne said the company was producing huge stocks of its current vaccine candidate in Belgium “at risk and scale”;, calling it “extremely exciting”.
“The hope here is that we have essentially come up with drugs that destroy the virus and ultimately prevent the patient’s condition from deteriorating,” he told the financial website Mail. “It’s money.”
“It was nice to see the first bottle coming out of the production line. It just put an extraordinary smile on my face when I saw that all this work really led to the product, ”he said.
But “we can only go as fast as science allows,” he said.
Pfizer expects to know if the vaccine is valid by the end of this month, but the company has yet to prove that the shot is safe and can be manufactured properly to obtain a so-called emergency permit, CEO Albert Burla said Friday.
If it is safe, he expects his company to apply for emergency use in the United States in the third week of November.
“We are working at the speed of science,” he said.